As filed with the Securities and Exchange Commission on February 25, 2025.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE
SECURITIES EXCHANGE ACT OF 1934
ABRDN EMERGING MARKETS EX-CHINA FUND, INC.
(Name of Subject Company (issuer))
ABRDN EMERGING MARKETS EX-CHINA FUND, INC.
(Name of Filing Person (offeror))
COMMON STOCK,
$0.001 PAR VALUE PER SHARE
(Title of Class of Securities)
168834109
(CUSIP Number of Class of Securities)
Lucia Sitar, Esq.
abrdn Emerging Markets ex-China Fund, Inc.
c/o abrdn Inc.
1900 Market Street, Suite 200
Philadelphia, Pennsylvania 19103
Telephone: (215) 405-5773
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications on Behalf of the Person(s) Filing Statement)
Copy to:
Thomas C. Bogle, Esq.
William J. Bielefeld, Esq.Dechert LLP
1900 K Street N.W.
Washington D.C. 20006
☐ Check box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
Check the appropriate boxes to designate any transactions to which this statement relates:
☐ third party tender offer subject to Rule 14d-1
☒ issuer tender offer subject to Rule 13e-4
☐ going-private transaction subject to Rule 13e-3
☐ amendment to Schedule 13D under Rule 13d-2
Check the following box if the filing is a final amendment reporting the results of the tender offer: ☒
Introductory Statement
This Amendment No. 2 hereby amends and supplements the Issuer Tender Offer Statement on Schedule TO initially filed by abrdn Emerging Markets ex-China Fund, Inc. (formerly known as abrdn Emerging Markets Equity Income Fund, Inc.), a Maryland corporation (the “Fund”), with the Securities and Exchange Commission (the “Commission”) on January 21, 2025 (as amended on February 21, 2025 and as further amended hereby, the “Schedule TO”) in order to update Item 12 to add exhibit (a)(7), a copy of the press release issued by the Fund dated February 25, 2025 announcing the final results of the offer and the information contained therein is incorporated by reference.
Except as amended herein, the information set forth in the Offer to Purchase and the related Letter of Transmittal is incorporated herein by reference in answer to Items 1 through 11 of Schedule TO.
1 Incorporated by reference to the Fund’s Schedule TO-I, as filed with the Commission on January 21, 2025.
2 Incorporated by reference to the Fund’s Schedule TO-I/A, as filed with the Commission on February 21, 2025.
3 Filed herewith.